Loading…
Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification
Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2. In the present study, 246 cases of meningioma were reclassified according to the WHO...
Saved in:
Published in: | Tumori 2008-05, Vol.94 (3), p.389-397 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533 |
---|---|
cites | cdi_FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533 |
container_end_page | 397 |
container_issue | 3 |
container_start_page | 389 |
container_title | Tumori |
container_volume | 94 |
creator | Uzüm, Nüket Ataoğlu, Gülen Akyol Omür |
description | Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2.
In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system. The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined. Follow-up data were available for only 80 patients.
A correlation was found between all morphologic parameters except for brain invasion. These parameters were related to a poor prognosis. There was no statistically significant difference in the prognosis between WHO grade I and grade II, whereas these two grades collectively exhibited significantly better survival than WHO grade III. Immunohistochemical staining for Ki-67 and bcl-2 was performed, and correlations between their expressions and other clinicopathological findings were investigated. Ki-67 and bcl-2 expression was correlated with tumor grade, and the higher the tumor grade, the higher the Ki-67 and bcl-2 expression. In conclusion, tumor grade appeared to be the most important parameter for a prognosis of meningiomas.
Ki-67 and bcl-2 expression might participate in carcinogenesis and when used with the grading system could provide additional benefit in assessing the biological behavior of the tumor. |
doi_str_mv | 10.1177/030089160809400316 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_030089160809400316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18705408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533</originalsourceid><addsrcrecordid>eNplkE1LAzEQhoMotlb_gAfJH1idfGw2e5SiViz0onhcptmkjexuliQq_ntbWvDgaXiH95mBh5BrBreMVdUdCABdMwUaagkgmDohUw5CF7zk9SmZ7gvFvjEhFyl9AEjgSp2TCdMVlBL0lHwtfMphxLwNXdh4gx0dMWJvs42Jfvu8pS--UBXFoaVr0xWc-oHmraVjDJshJJ9ocLS3gx82PvSYKBoTYruLNAf6vlhRDgDUdJiSd7sP2Yfhkpw57JK9Os4ZeXt8eJ0viuXq6Xl-vyyMAJYLrKXSIFsrylpztMYJzaG0oEtRK5SqRXTSid2eOWOFLm0LrXL12mlpSyFmhB_umhhSitY1Y_Q9xp-GQbOX2PyXuINuDtD4ue5t-4ccrYlfevts3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification</title><source>Sage Journals Online</source><creator>Uzüm, Nüket ; Ataoğlu, Gülen Akyol Omür</creator><creatorcontrib>Uzüm, Nüket ; Ataoğlu, Gülen Akyol Omür</creatorcontrib><description>Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2.
In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system. The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined. Follow-up data were available for only 80 patients.
A correlation was found between all morphologic parameters except for brain invasion. These parameters were related to a poor prognosis. There was no statistically significant difference in the prognosis between WHO grade I and grade II, whereas these two grades collectively exhibited significantly better survival than WHO grade III. Immunohistochemical staining for Ki-67 and bcl-2 was performed, and correlations between their expressions and other clinicopathological findings were investigated. Ki-67 and bcl-2 expression was correlated with tumor grade, and the higher the tumor grade, the higher the Ki-67 and bcl-2 expression. In conclusion, tumor grade appeared to be the most important parameter for a prognosis of meningiomas.
Ki-67 and bcl-2 expression might participate in carcinogenesis and when used with the grading system could provide additional benefit in assessing the biological behavior of the tumor.</description><identifier>ISSN: 0300-8916</identifier><identifier>EISSN: 2038-2529</identifier><identifier>DOI: 10.1177/030089160809400316</identifier><identifier>PMID: 18705408</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Biomarkers, Tumor - analysis ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Ki-67 Antigen - analysis ; Male ; Meningeal Neoplasms - chemistry ; Meningeal Neoplasms - classification ; Meningeal Neoplasms - pathology ; Meningioma - chemistry ; Meningioma - classification ; Meningioma - pathology ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Proto-Oncogene Proteins c-bcl-2 - analysis ; Retrospective Studies ; Severity of Illness Index ; World Health Organization</subject><ispartof>Tumori, 2008-05, Vol.94 (3), p.389-397</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533</citedby><cites>FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18705408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uzüm, Nüket</creatorcontrib><creatorcontrib>Ataoğlu, Gülen Akyol Omür</creatorcontrib><title>Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification</title><title>Tumori</title><addtitle>Tumori</addtitle><description>Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2.
In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system. The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined. Follow-up data were available for only 80 patients.
A correlation was found between all morphologic parameters except for brain invasion. These parameters were related to a poor prognosis. There was no statistically significant difference in the prognosis between WHO grade I and grade II, whereas these two grades collectively exhibited significantly better survival than WHO grade III. Immunohistochemical staining for Ki-67 and bcl-2 was performed, and correlations between their expressions and other clinicopathological findings were investigated. Ki-67 and bcl-2 expression was correlated with tumor grade, and the higher the tumor grade, the higher the Ki-67 and bcl-2 expression. In conclusion, tumor grade appeared to be the most important parameter for a prognosis of meningiomas.
Ki-67 and bcl-2 expression might participate in carcinogenesis and when used with the grading system could provide additional benefit in assessing the biological behavior of the tumor.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kaplan-Meier Estimate</subject><subject>Ki-67 Antigen - analysis</subject><subject>Male</subject><subject>Meningeal Neoplasms - chemistry</subject><subject>Meningeal Neoplasms - classification</subject><subject>Meningeal Neoplasms - pathology</subject><subject>Meningioma - chemistry</subject><subject>Meningioma - classification</subject><subject>Meningioma - pathology</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Proto-Oncogene Proteins c-bcl-2 - analysis</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>World Health Organization</subject><issn>0300-8916</issn><issn>2038-2529</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNplkE1LAzEQhoMotlb_gAfJH1idfGw2e5SiViz0onhcptmkjexuliQq_ntbWvDgaXiH95mBh5BrBreMVdUdCABdMwUaagkgmDohUw5CF7zk9SmZ7gvFvjEhFyl9AEjgSp2TCdMVlBL0lHwtfMphxLwNXdh4gx0dMWJvs42Jfvu8pS--UBXFoaVr0xWc-oHmraVjDJshJJ9ocLS3gx82PvSYKBoTYruLNAf6vlhRDgDUdJiSd7sP2Yfhkpw57JK9Os4ZeXt8eJ0viuXq6Xl-vyyMAJYLrKXSIFsrylpztMYJzaG0oEtRK5SqRXTSid2eOWOFLm0LrXL12mlpSyFmhB_umhhSitY1Y_Q9xp-GQbOX2PyXuINuDtD4ue5t-4ccrYlfevts3A</recordid><startdate>20080501</startdate><enddate>20080501</enddate><creator>Uzüm, Nüket</creator><creator>Ataoğlu, Gülen Akyol Omür</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080501</creationdate><title>Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification</title><author>Uzüm, Nüket ; Ataoğlu, Gülen Akyol Omür</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kaplan-Meier Estimate</topic><topic>Ki-67 Antigen - analysis</topic><topic>Male</topic><topic>Meningeal Neoplasms - chemistry</topic><topic>Meningeal Neoplasms - classification</topic><topic>Meningeal Neoplasms - pathology</topic><topic>Meningioma - chemistry</topic><topic>Meningioma - classification</topic><topic>Meningioma - pathology</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Proto-Oncogene Proteins c-bcl-2 - analysis</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uzüm, Nüket</creatorcontrib><creatorcontrib>Ataoğlu, Gülen Akyol Omür</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Tumori</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uzüm, Nüket</au><au>Ataoğlu, Gülen Akyol Omür</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification</atitle><jtitle>Tumori</jtitle><addtitle>Tumori</addtitle><date>2008-05-01</date><risdate>2008</risdate><volume>94</volume><issue>3</issue><spage>389</spage><epage>397</epage><pages>389-397</pages><issn>0300-8916</issn><eissn>2038-2529</eissn><abstract>Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2.
In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system. The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined. Follow-up data were available for only 80 patients.
A correlation was found between all morphologic parameters except for brain invasion. These parameters were related to a poor prognosis. There was no statistically significant difference in the prognosis between WHO grade I and grade II, whereas these two grades collectively exhibited significantly better survival than WHO grade III. Immunohistochemical staining for Ki-67 and bcl-2 was performed, and correlations between their expressions and other clinicopathological findings were investigated. Ki-67 and bcl-2 expression was correlated with tumor grade, and the higher the tumor grade, the higher the Ki-67 and bcl-2 expression. In conclusion, tumor grade appeared to be the most important parameter for a prognosis of meningiomas.
Ki-67 and bcl-2 expression might participate in carcinogenesis and when used with the grading system could provide additional benefit in assessing the biological behavior of the tumor.</abstract><cop>United States</cop><pmid>18705408</pmid><doi>10.1177/030089160809400316</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-8916 |
ispartof | Tumori, 2008-05, Vol.94 (3), p.389-397 |
issn | 0300-8916 2038-2529 |
language | eng |
recordid | cdi_crossref_primary_10_1177_030089160809400316 |
source | Sage Journals Online |
subjects | Adult Aged Biomarkers, Tumor - analysis Disease-Free Survival Female Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Kaplan-Meier Estimate Ki-67 Antigen - analysis Male Meningeal Neoplasms - chemistry Meningeal Neoplasms - classification Meningeal Neoplasms - pathology Meningioma - chemistry Meningioma - classification Meningioma - pathology Middle Aged Predictive Value of Tests Prognosis Proto-Oncogene Proteins c-bcl-2 - analysis Retrospective Studies Severity of Illness Index World Health Organization |
title | Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A39%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histopathological%20parameters%20with%20Ki-67%20and%20bcl-2%20in%20the%20prognosis%20of%20meningiomas%20according%20to%20WHO%202000%20classification&rft.jtitle=Tumori&rft.au=Uz%C3%BCm,%20N%C3%BCket&rft.date=2008-05-01&rft.volume=94&rft.issue=3&rft.spage=389&rft.epage=397&rft.pages=389-397&rft.issn=0300-8916&rft.eissn=2038-2529&rft_id=info:doi/10.1177/030089160809400316&rft_dat=%3Cpubmed_cross%3E18705408%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c301t-a946804de35982aecf38205e085396a46daaf4f3cf31fce385ed0d6f9bf84e533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18705408&rfr_iscdi=true |